The FTC is cracking down on big healthcare companies
Corporations are becoming the norm in health care, and agencies like the Federal Trade Commission (FTC) know that what's good for business isn't necessarily good for patients.
Americans are spending way too much on health care, and getting far too little in return. Together we can bring down the cost of prescription drugs, prevent surprise medical bills, get providers to rein in skyrocketing costs, and more.
Corporations are becoming the norm in health care, and agencies like the Federal Trade Commission (FTC) know that what's good for business isn't necessarily good for patients.
U.S. Supreme Court on Monday declined to review a federal circuit court decision that imperils a critical method that many generic drug makers use to win approval. The court denied a petition of certiorari in Teva Pharmaceuticals USA, Inc. V GlaxoSmithKline LLC, Et. Al., allowing the divided lower court's decision to stand. This action can have dramatically limit competition from lower-priced generic and biosimilar medicines.
We are looking for patient stories about the high prices of medicines.
Fast food giant sets targets for responsible antibiotic use in its global beef supply chain
Investigative journalists allege U.S. beef producers use antibiotics World Health Organization deems most valuable to humans